Abstract

Treatment of High Risk (HR) Smoldering Multiple Myeloma (SMM) with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Lenalidomide Maintenance (-R): A Phase 2 Clinical and Correlative Study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy in Newly Diagnosed Multiple Myeloma: Final Results from a Clinical and Correlative Phase 2 Study
Jenna Rispoli ... Dennis Verducci
Blood | VOL. 136
Jenna Rispoli, et. al.Jenna Rispoli ... Dennis Verducci
05 Nov 2020
Sustained Minimal Residual Disease (MRD) Negativity and Clinical Efficacy in Transplant-Ineligible (TIE) Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Treated with Daratumumab-Based Regimens: Analysis of Maia and Alcyone
... Bruno Paiva
Blood | VOL. 136
, et. al. ... Bruno Paiva
05 Nov 2020
Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre-Transplant Induction and Post-Transplant Consolidation in Newly Diagnosed Multiple Myeloma Patients
Albert Oriol Rocafiguera ... Roman Hajek
Blood | VOL. 142
Albert Oriol Rocafiguera, et. al.Albert Oriol Rocafiguera ... Roman Hajek
28 Nov 2023
Daratumumab (DARA) with Bortezomib, Thalidomide, and Dexamethasone (VTd) in Transplant-Eligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Minimal Residual Disease (MRD) Negativity in Cassiopeia Part 1 and Part 2
... Aurore Perrot
Blood | VOL. 138
, et. al. ... Aurore Perrot
05 Nov 2021
View more papers

More From: Blood

Paper Title
Journal
Date
Author
How I manage pregnant patients who are alloimmunized to RBC antigens.
Helen Frances Savoia ... Stefan Charles Kane
Blood | VOL. -
Helen Frances Savoia, et. al.Helen Frances Savoia ... Stefan Charles Kane
14 May 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
Ross S Firestone ... David J Chung
Blood | VOL. -
Ross S Firestone, et. al.Ross S Firestone ... David J Chung
10 May 2024
Elevating fetal hemoglobin – recently discovered regulators and mechanisms
Gerd A Blobel ... Eugene Khandros
Blood | VOL. -
Gerd A Blobel, et. al.Gerd A Blobel ... Eugene Khandros
10 May 2024
How I treat challenging transfusion cases in sickle cell disease
Stella T Chou ... Jeanne E Hendrickson
Blood | VOL. -
Stella T Chou, et. al.Stella T Chou ... Jeanne E Hendrickson
10 May 2024
View more papers